COVID-19 mRNA vaccine (aimbio)

N/A

Report date: 2026/05/12 09:10:19

Base Information

Drug NameCOVID-19 mRNA vaccine (aimbio)
Drug Alias NameLVRNA009
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPakistanMainland ChinaKenya
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAim Vaccine Co LtdZhuhai Lifanda Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai Lifanda Biotechnology Co LtdAIM Innovation Biotechnology (Shanghai) Co LtdLiveRNA Therapeutics Inc +[5] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A